Zenobia Therapeutics Inc is a San Diego-based company specializing in fragment-based lead discovery for the development of treatments for neurodegenerative diseases. With a focus on the central nervous system (CNS), their products and services have successfully yielded hits for a diverse range of targets worldwide.
Founded in 2008, Zenobia Therapeutics expanded in 2014 to include Zenobia Fragments, a division dedicated to supplying highly core diverse fragments and unique reagents for protein solubilization and crystallization. Complementing their product offerings, Zenobia also provides screening and structural biology services to support fragment library purchases, solidifying their position as a leader in fragment-based lead discovery and CNS disease research.
Generated from the website